These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 18202762

  • 21. Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response.
    Ferrario A, Rucker N, Wong S, Luna M, Gomer CJ.
    Cancer Res; 2007 May 15; 67(10):4989-95. PubMed ID: 17510430
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of oxygen consumption of culture medium and in vitro photodynamic effect of talaporfin sodium in lung tumor cells.
    Tomioka Y, Kushibiki T, Awazu K.
    Photomed Laser Surg; 2010 Jun 15; 28(3):385-90. PubMed ID: 19860571
    [Abstract] [Full Text] [Related]

  • 23. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Kirveliene V, Grazeliene G, Dabkeviciene D, Micke I, Kirvelis D, Juodka B, Didziapetriene J.
    Cancer Chemother Pharmacol; 2006 Jan 15; 57(1):65-72. PubMed ID: 16001168
    [Abstract] [Full Text] [Related]

  • 24. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model.
    Ferrario A, Kessel D, Gomer CJ.
    Cancer Res; 1992 May 15; 52(10):2890-3. PubMed ID: 1581904
    [Abstract] [Full Text] [Related]

  • 25. Alterations in mitochondrial and apoptosis-regulating gene expression in photodynamic therapy-resistant variants of HT29 colon carcinoma cells.
    Shen XY, Zacal N, Singh G, Rainbow AJ.
    Photochem Photobiol; 2005 May 15; 81(2):306-13. PubMed ID: 15560738
    [Abstract] [Full Text] [Related]

  • 26. Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study.
    Kikuchi T, Asakura T, Aihara H, Shiraki M, Takagi S, Kinouchi Y, Aizawa K, Shimosegawa T.
    Anticancer Res; 2003 May 15; 23(6C):4897-900. PubMed ID: 14981942
    [Abstract] [Full Text] [Related]

  • 27. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.
    Colombo LL, Vanzulli SI, Villanueva A, Cañete M, Juarranz A, Stockert JC.
    Int J Oncol; 2005 Oct 15; 27(4):1053-9. PubMed ID: 16142323
    [Abstract] [Full Text] [Related]

  • 28. Studies on preparation and photodynamic mechanism of chlorin P6-13,15-N-(cyclohexyl)cycloimide (Chlorin-H) and its antitumor effect for photodynamic therapy in vitro and in vivo.
    Yan YJ, Zheng MZ, Chen ZL, Yu XH, Yang XX, Ding ZL, Xu L.
    Bioorg Med Chem; 2010 Sep 01; 18(17):6282-91. PubMed ID: 20691601
    [Abstract] [Full Text] [Related]

  • 29. Changes in VEGF level and tumor growth characteristics during lewis lung carcinoma progression towards cis-DDP resistance.
    Pyaskovskaya ON, Dasyukevich OI, Kolesnik DL, Garmanchouk LV, Todor IN, Solyanik GI.
    Exp Oncol; 2007 Sep 01; 29(3):197-202. PubMed ID: 18004244
    [Abstract] [Full Text] [Related]

  • 30. Killing tumor cells: the effect of photodynamic therapy using mono-L-aspartyl chlorine and NS-398.
    Harvey EH, Webber J, Kessel D, Fromm D.
    Am J Surg; 2005 Mar 01; 189(3):302-5. PubMed ID: 15792755
    [Abstract] [Full Text] [Related]

  • 31. Dying cells program their expedient disposal: serum amyloid P component upregulation in vivo and in vitro induced by photodynamic therapy of cancer.
    Merchant S, Sun J, Korbelik M.
    Photochem Photobiol Sci; 2007 Dec 01; 6(12):1284-9. PubMed ID: 18046483
    [Abstract] [Full Text] [Related]

  • 32. Synthesis and photobiological study of a novel chlorin photosensitizer BCPD-18MA for photodynamic therapy.
    Zhang J, Deng L, Yao J, Gu P, Yang F, Wang X, Liu W, Zhang Y, Ke X, Jing X, Chen J.
    Bioorg Med Chem; 2011 Sep 15; 19(18):5520-8. PubMed ID: 21855352
    [Abstract] [Full Text] [Related]

  • 33. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA, Gollnick SO, Camacho SH, Greco WR, Cheney RT.
    Cancer Res; 2003 Nov 15; 63(22):7584-90. PubMed ID: 14633671
    [Abstract] [Full Text] [Related]

  • 34. Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency.
    Jee SH, Shen SC, Chiu HC, Tsai WL, Kuo ML.
    Oncogene; 2001 Jan 11; 20(2):198-208. PubMed ID: 11313947
    [Abstract] [Full Text] [Related]

  • 35. New two-photon activated photodynamic therapy sensitizers induce xenograft tumor regressions after near-IR laser treatment through the body of the host mouse.
    Starkey JR, Rebane AK, Drobizhev MA, Meng F, Gong A, Elliott A, McInnerney K, Spangler CW.
    Clin Cancer Res; 2008 Oct 15; 14(20):6564-73. PubMed ID: 18927297
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
    Chan AL, Juarez M, Allen R, Volz W, Albertson T.
    Photodermatol Photoimmunol Photomed; 2005 Apr 15; 21(2):72-8. PubMed ID: 15752124
    [Abstract] [Full Text] [Related]

  • 37. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.
    Taber SW, Fingar VH, Coots CT, Wieman TJ.
    Clin Cancer Res; 1998 Nov 15; 4(11):2741-6. PubMed ID: 9829737
    [Abstract] [Full Text] [Related]

  • 38. mTHPC-mediated photodynamic treatment up-regulates the cytokines VEGF and IL-1alpha.
    Dabkeviciene D, Sasnauskiene A, Leman E, Kvietkauskaite R, Daugelaviciene N, Stankevicius V, Jurgelevicius V, Juodka B, Kirveliene V.
    Photochem Photobiol; 2012 Nov 15; 88(2):432-9. PubMed ID: 22171990
    [Abstract] [Full Text] [Related]

  • 39. Fractionated photodynamic therapy for a human oral squamous cell carcinoma xenograft.
    Togashi H, Uehara M, Ikeda H, Inokuchi T.
    Oral Oncol; 2006 May 15; 42(5):526-32. PubMed ID: 16466960
    [Abstract] [Full Text] [Related]

  • 40. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes.
    Maugain E, Sasnouski S, Zorin V, Merlin JL, Guillemin F, Bezdetnaya L.
    Oncol Rep; 2004 Sep 15; 12(3):639-45. PubMed ID: 15289849
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.